کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
6001733 | 1182956 | 2014 | 9 صفحه PDF | دانلود رایگان |
- We collected data from 4742 cases and 4066 controls of 17 studies.
- A meta-analysis of association between eNOS G894T and thrombotic disease was made.
- eNOS G894T polymorphism increases the risk of venous thrombosis.
- In Asian population eNOS G894T polymorphism is a risk factor of thrombotic disease.
- eNOS G894T polymorphism has no association with carotid atherosclerosis.
IntroductionEndothelial nitric oxide synthase (eNOS) 894Â GÂ >Â T polymorphism may influence the risk of thrombotic disease, but data from published studies with low statistical power are inconclusive. To investigate the association between the gene polymorphism and thrombotic disease, a meta-analysis was performed.Materials and MethodsCase-control studies evaluating the association between the eNOS G894T polymorphism, Glu298Asp and thrombotic disease were searched in PubMed, OVID, Web of Science, Google Scholar and China Biology Medicine disc (CBM). Data were available for 4742 cases and 4066 controls from 17 studies.ResultsIn all, although there was a significant association between G894T and thrombotic disease (G/TÂ +Â T/T vs. G/G: ORÂ =Â 1.364, 95%CIÂ =Â 1.126-1.652, PÂ =Â 0.001; T/T vs. G/TÂ +Â G/G: ORÂ =Â 1.861, 95%CIÂ =Â 1.207-2.870, PÂ =Â 0.005; TT vs. GG: ORÂ =Â 1.938, 95%CIÂ =Â 1.244-3.021, PÂ =Â 0.003; G/T vs. G/G: ORÂ =Â 1.225, 95%CIÂ =Â 1.022-1.469, PÂ =Â 0.028), there was significant heterogeneity among studies (P*Â <Â 0.001). In subgroup analysis, there was significant association with no heterogeneity in venous thrombosis (G/TÂ +Â T/T vs. G/G: ORÂ =Â 1.409, 95%CIÂ =Â 1.135-1.750, PÂ =Â 0.002, P*Â =Â 0.508; T/T vs. G/G: ORÂ =Â 1.640, 95%CIÂ =Â 1.011-2.660, PÂ =Â 0.045, P*Â =Â 0.333; G/T vs. G/G: ORÂ =Â 1.357, 95%CIÂ =Â 1.082-1.701, PÂ =Â 0.008, P*Â =Â 0.595) and in Asian population (G/TÂ +Â T/T vs. G/G: ORÂ =Â 1.722, 95%CIÂ =Â 1.443-2.055, PÂ <Â 0.001, P*Â =Â 0.541; T/T vs. G/TÂ +Â G/G: ORÂ =Â 2.357, 95%CIÂ =Â 1.389-4.000, PÂ =Â 0.001, P*Â =Â 0.908; T/T vs. G/G: ORÂ =Â 2.813, 95%CIÂ =Â 1.645-4.810, PÂ <Â 0.001, P*Â =Â 0.969; G/T vs. G/G: ORÂ =Â 1.645, 95%CIÂ =Â 1.370-1.975, PÂ <Â 0.001, P*Â =Â 0.489).ConclusionsFindings of this meta-analysis demonstrated that eNOS G894T polymorphism may be a risk factor for venous thrombosis, and in Asia the polymorphism may increase the risk of developing thrombotic disease.
Journal: Thrombosis Research - Volume 134, Issue 5, November 2014, Pages 1057-1065